The Promise and Disappointment of Neoadjuvant Chemotherapy and Transurethral Resection for Muscle-invasive Bladder Cancer: Updated Results and Long-term Follow-up

Conclusions Long-term follow-up demonstrates a subset of patients achieving good long-term outcomes while preserving their bladder. However, we also demonstrate the inability to reliably identify this subset of patients given current clinical and pathologic markers. Until we are able to achieve that goal, the safest oncologic approach remains NAC followed by RC. (Source: Urology Practice)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2tBaiOR
via IFTTT